However, it may prove to be more informative when coupled with other biomarkers of PM, as is the case for preeclampsia, where the utility of sEng as a prognostic biomarker is strengthened when combined with measurements of soluble Flt-1 and placental growth factor [21], [29]. The gene discussed is FLT1; the disease is preeclampsia.